Resveratrol protects against TNF-α-induced injury in human umbilical endothelial cells through promoting sirtuin-1-induced repression of NF-KB and p38 MAPK

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Pan, Wei ^a   Yu, Huizhen ^a,b   Huang, Shujie ^b   Zhu, Pengli ^a,b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fujian Institute of Geriatrics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; TRANSCRIPTION FACTOR RELA; SIRT1 PROTEIN, HUMAN; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIGENS, CD40; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIRTUIN 1; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 84958191382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147034     Document Type: Article

References (44)

1. Rizvi M, Pathak D, Freedman JE, Chakrabarti S. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends in molecular medicine. 2008; 14(12):530-8. doi: 10.1016/j. molmed.2008.09.006 PMID: 18977174
2. Zhou L, Stordeur P, de Lavareille A, Thielemans K, Capel P, Goldman M, et al. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thrombosis and haemostasis. 1998; 79(5):1025-8. PMID: 9609241
3. Tousoulis D, Androulakis E, Papageorgiou N, Briasoulis A, Siasos G, Antoniades C, et al. From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand. Trends in cardiovascular medicine. 2010; 20(5):153-64. doi: 10.1016/j.tcm.2010.12.004 PMID: 21742271
4. Bae YS, Oh H, Rhee SG, Yoo YD. Regulation of reactive oxygen species generation in cell signaling. Molecules and cells. 2011; 32(6):491-509. doi: 10.1007/s10059-011-0276-3 PMID: 22207195
5. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation. 2002; 106(8):981-6. PMID: 12186804
6. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene. 2007; 26 (22):3100-12. PMID: 17496909
7. Tsuruoka S, Hiwatashi A, Usui J, Yamagata K. The mitochondrial SIRT1-PGC-1alpha axis in podocyte injury. Kidney international. 2012; 82(7):735-6. doi: 10.1038/ki.2012.182 PMID: 22975995
8. Kutlesa Z, Budimir Mrsic D. Wine and bone health: a review. Journal of bone and mineral metabolism. 2015.
9. Ido Y, Duranton A, Lan F, Weikel KA, Breton L, Ruderman NB. Resveratrol prevents oxidative stressinduced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. PloS one. 2015; 10(2):e0115341. doi: 10.1371/journal.pone.0115341 PMID: 25647160
10. Chong E, Chang SL, Hsiao YW, Singhal R, Liu SH, Leha T, et al. Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation. Heart rhythm: the official journal of the Heart Rhythm Society. 2015; 12(5):1046-56.
11. Lee JH, Kim JS, Park SY, Lee YJ. Resveratrol induces human keratinocyte damage via the activation of class III histone deacetylase, Sirt1. Oncology reports. 2015.
12. Yoshizaki T, Milne JC, Imamura T, Schenk S, Sonoda N, Babendure JL, et al. SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Molecular and cellular biology. 2009; 29 (5):1363-74. doi: 10.1128/MCB.00705-08 PMID: 19103747
13. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell cycle. 2011; 10(4):640-7. PMID: 21293192
14. Harijith A, Ebenezer DL, Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Frontiers in physiology. 2014; 5:352. doi: 10.3389/fphys.2014.00352 PMID: 25324778
15. Csiszar A, Labinskyy N, Podlutsky A, Kaminski PM, Wolin MS, Zhang C, et al. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. American journal of physiology Heart and circulatory physiology. 2008; 294(6): H2721-35. doi: 10.1152/ajpheart.00235.2008 PMID: 18424637
16. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nature protocols. 2007; 2(3):481-5. PMID: 17406610
17. Wissel H, Muller T, Rudiger M, Krull M, Wauer RR. Contact of Chlamydophila pneumoniae with type II cell triggers activation of calcium-mediated NF-kappa B pathway. Biochimica et biophysica acta. 2005; 1743(1-2):37-48. PMID: 15777838
18. Wissel H, Schulz C, Koehne P, Richter E, Maass M, Rudiger M. Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes. Respiratory research. 2005; 6:51. PMID: 15935092
19. Sassi N, Mattarei A, Azzolini M, Szabo I, Paradisi C, Zoratti M, et al. Cytotoxicity of mitochondria-targeted resveratrol derivatives: interactions with respiratory chain complexes and ATP synthase. Biochimica et biophysica acta. 2014; 1837(10):1781-9. doi: 10.1016/j.bbabio.2014.06.010 PMID: 24997425
20. Dymicka-Piekarska V, Korniluk A, Gryko M, Siergiejko E, Kemona H. Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients. The International journal of biological markers. 2014; 29(3):e261-7. doi: 10.5301/jbm.5000083 PMID: 24706377
21. Volz MS, Moos V, Allers K, Luge E, Mayer-Scholl A, Nockler K, et al. Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis. Clinical and vaccine immunology: CVI. 2015.
22. de Souza IC, Meira Martins LA, de Vasconcelos M, de Oliveira CM, Barbe-Tuana F, Andrade CB, et al. Resveratrol Regulates the Quiescence-Like Induction of Activated Stellate Cells by Modulating the PPARgamma/SIRT1 Ratio. Journal of cellular biochemistry. 2015.
23. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell. 2008; 132(3):344-62. doi: 10.1016/j.cell.2008.01.020 PMID: 18267068
24. Sun JM, Chen HY, Davie JR. Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin. The Journal of biological chemistry. 2007; 282(45):33227-36. PMID: 17827154
25. Bosutti A, Degens H. The impact of resveratrol and hydrogen peroxide on muscle cell plasticity shows a dose-dependent interaction. Scientific reports. 2015; 5:8093. doi: 10.1038/srep08093 PMID: 25627702
26. Gocmen AY, Burgucu D, Gumuslu S. Effect of resveratrol on platelet activation in hypercholesterolemic rats: CD40-CD40L system as a potential target. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2011; 36(3):323-30. doi: 10.1139/h11-022 PMID: 21574786
27. Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology. 2010; 129(4):525-35. doi: 10.1111/j.1365-2567.2009.03205.x PMID: 20002210
28. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009; 458(7241):1056-60. doi: 10.1038/nature07813 PMID: 19262508
29. Takizawa Y, Kosuge Y, Awaji H, Tamura E, Takai A, Yanai T, et al. Up-regulation of endothelial nitric oxide synthase (eNOS), silent mating type information regulation 2 homologue 1 (SIRT1) and autophagy-related genes by repeated treatments with resveratrol in human umbilical vein endothelial cells. The British journal of nutrition. 2013; 110(12):2150-5. doi: 10.1017/S0007114513001670 PMID: 23750556
30. Yang L, Zhang J, Yan C, Zhou J, Lin R, Lin Q, et al. SIRT1 regulates CD40 expression induced by TNFalpha via NF-kB pathway in endothelial cells. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2012; 30(5):1287-98.
31. Lin QQ, Yan CF, Lin R, Zhang JY, Wang WR, Yang LN, et al. SIRT1 regulates TNF-alpha-induced expression of CD40 in 3T3-L1 adipocytes via NF-kappaB pathway. Cytokine. 2012; 60(2):447-55. doi: 10.1016/j.cyto.2012.05.025 PMID: 22717288
32. Holthoff JH, Woodling KA, Doerge DR, Burns ST, Hinson JA, Mayeux PR. Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochemical pharmacology. 2010; 80 (8):1260-5. doi: 10.1016/j.bcp.2010.06.027 PMID: 20599800
33. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, et al. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochemical and biophysical research communications. 2003; 309(4):1017-26. PMID: 13679076
34. Dong WW, Liu YJ, Lv Z, Mao YF, Wang YW, Zhu XY, et al. Lung endothelial barrier protection by resveratrol involves inhibition of HMGB1 release and HMGB1-induced mitochondrial oxidative damage via an Nrf2-dependent mechanism. Free radical biology & medicine. 2015.
35. Thiel G, Rossler OG. Resveratrol stimulates AP-1-regulated gene transcription. Molecular nutrition & food research. 2014; 58(7):1402-13.
36. Roy SK, Chen Q, Fu J, Shankar S, Srivastava RK. Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PloS one. 2011; 6(9):e25166. doi: 10.1371/ journal.pone.0025166 PMID: 21980390
37. Yeh CB, Hsieh MJ, Lin CW, Chiou HL, Lin PY, Chen TY, et al. The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation. PloS one. 2013; 8(2):e56661. doi: 10.1371/journal.pone.0056661 PMID: 23437203
38. Dirks Naylor AJ. Cellular effects of resveratrol in skeletal muscle. Life sciences. 2009; 84(19-20):637-40. doi: 10.1016/j.lfs.2009.02.011 PMID: 19233212
39. Zhang J, Chen J, Yang J, Xu CW, Pu P, Ding JW, et al. Resveratrol attenuates oxidative stress induced by balloon injury in the rat carotid artery through actions on the ERK1/2 and NF-kappa B pathway. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2013; 31(2-3):230-41.
40. Basuroy S, Bhattacharya S, Tcheranova D, Qu Y, Regan RF, Leffler CW, et al. HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells. American journal of physiology Cell physiology. 2006; 291(5):C897-908. PMID: 16822952
41. Ghisays F, Brace CS, Yackly SM, Kwon HJ, Mills KF, Kashentseva E, et al. The N-Terminal Domain of SIRT1 Is a Positive Regulator of Endogenous SIRT1-Dependent Deacetylation and Transcriptional Outputs. Cell reports. 2015.
42. Gao Y, Kang L, Li C, Wang X, Sun C, Li Q, et al. Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway. Cardiovascular toxicology. 2015.
43. Xu H, Xiong C, He L, Wu B, Peng L, Cheng Y, et al. Trans-resveratrol attenuates high fatty acid-induced P2X7 receptor expression and IL-6 release in PC12 cells: possible role of P38 MAPK pathway. Inflammation. 2015; 38(1):327-37. doi: 10.1007/s10753-014-0036-6 PMID: 25348860
44. Guo R, Su Y, Liu B, Li S, Zhou S, Xu Y. Resveratrol suppresses oxidised low-density lipoproteininduced macrophage apoptosis through inhibition of intracellular reactive oxygen species generation, LOX-1, and the p38 MAPK pathway. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2014; 34(2):603-16.